Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07871786Phase 4Completed
Phase 4, randomised, single-blind trial in Dentinal hypersensitivity (DH) (2 arms), sponsored by Colgate-Palmolive. Primary endpoint: Change in Dentinal Hypersensitivity Score at 7 days. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07871786.